The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer.

MLA

Karaağaç, Mustafa, et al. “The XRCC1 and TP53 Gene Polymorphisms Are Associated with Advanced-Stage Disease and Early Distant Metastasis at Diagnosis in Non-Small Cell Lung Cancer.” Journal of Cancer Research & Therapeutics, vol. 19, no. 5, July 2023, pp. 1248–54. EBSCOhost, https://doi.org/10.4103/jcrt.jcrt_1657_21.

APA

Karaağaç, M., Geredeli, Ç., Yıldırım, M. S., Altınok, T., Dede, İ., İnal, A., Gül Zamani, A., Kaya, B., Demirkazık, A., Bozcuk, H., & Artaç, M. (2023). The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer. Journal of Cancer Research & Therapeutics, 19(5), 1248–1254. https://doi.org/10.4103/jcrt.jcrt_1657_21

Chicago

Karaağaç, Mustafa, Çağlayan Geredeli, Mahmut Selman Yıldırım, Tamer Altınok, İsa Dede, Ali İnal, Ayşe Gül Zamani, et al. 2023. “The XRCC1 and TP53 Gene Polymorphisms Are Associated with Advanced-Stage Disease and Early Distant Metastasis at Diagnosis in Non-Small Cell Lung Cancer.” Journal of Cancer Research & Therapeutics 19 (5): 1248–54. doi:10.4103/jcrt.jcrt_1657_21.